AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,366,350 | -17.6% | 91,091 | -15.3% | 0.19% | -9.5% |
| Q2 2023 | $7,727,321 | +15.7% | 107,533 | -0.7% | 0.21% | +8.8% |
| Q1 2023 | $6,678,772 | +89740.9% | 108,281 | +12.3% | 0.19% | -17.2% |
| Q4 2022 | $7,434 | -99.8% | 96,386 | -9.8% | 0.23% | +51.3% |
| Q3 2022 | $4,767,000 | -11.9% | 106,839 | -24.4% | 0.15% | -5.5% |
| Q2 2022 | $5,411,000 | -21.1% | 141,284 | -14.7% | 0.16% | +0.6% |
| Q1 2022 | $6,857,000 | +52.1% | 165,656 | +38.9% | 0.16% | +80.0% |
| Q4 2021 | $4,507,000 | +18.0% | 119,298 | +2.9% | 0.09% | +13.9% |
| Q3 2021 | $3,821,000 | -59.2% | 115,939 | -16.6% | 0.08% | -53.0% |
| Q2 2021 | $9,373,000 | +28.9% | 138,935 | +8.2% | 0.17% | +24.4% |
| Q1 2021 | $7,270,000 | -39.0% | 128,405 | -12.2% | 0.14% | -40.5% |
| Q4 2020 | $11,921,000 | – | 146,325 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |